1-3 of 3
Jean-François Abgrall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Peg-Interferon-α2a In Myelofibrosis: a Study of the FIM and GEM French Cooperative Groups

Jean-Christophe Ianotto, Françoise Boyer-Perrard, Jean-Loup Demory, MD, Jerome Rey, Lydia Roy, MD, Christian Berthou, Brigitte Dupriez, MD, Dana Ranta, Mireille Potard, Michele Schoenwald, Jean-François Abgrall, Jean-Jacques Kiladjian, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4103.
https://doi.org/10.1182/blood.V116.21.4103.4103
Published: 2010
Journal Articles

Risk Stratification for Survival and Clonal Progression in Essential Thrombocythemia (ET): Result of a Prospective Study of 108 Patients with Very Long Term Follow up.

Jean-Jacques Kiladjian, Sylvie Chevret, Jean-François Abgrall, Yasmine Chait, Jean Briere
Journal: Blood
Blood (2008) 112 (11): 1747.
https://doi.org/10.1182/blood.V112.11.1747.1747
Published: 2008
Journal Articles

Comparison of Autologous Bone Marrow Transplantation and Intensive Chemotherapy as Postremission Therapy in Adult Acute Myeloid Leukemia

Jean-Luc Harousseau, Jean-Yves Cahn, Bernard Pignon, Francis Witz, Noël Milpied, Martine Delain, Bruno Lioure, Thierry Lamy, Bernard Desablens, François Guilhot, Denis Caillot, Jean-François Abgrall, Sylvie Francois, Jean Briere, Denis Guyotat, Philippe Casassus, Bruno Audhuy, Zéra Tellier, Patrick Hurteloup, Patrick Herve
Journal: Blood
Blood (1997) 90 (8): 2978–2986.
https://doi.org/10.1182/blood.V90.8.2978
Published: 1997